New Hampshire Senate Bill SB180

New Hampshire 2023 Regular Session

• Introduced: 1/20/23
• Refer: 1/20/23
• Report Pass: 2/16/23
• Engrossed: 3/20/23
• Refer: 3/20/23

Caption

Relative to product labeling and information guide requirements for cannabis products and the prohibition of the sale of hemp products containing certain levels of THC.

Impact

In addition to labeling improvements, SB180 specifically prohibits the sale of hemp-derived products containing tetrahydrocannabinol (THC) levels exceeding 0.03% on a dry weight basis. This regulation targets all formulations of THC, including variants such as delta-8 and delta-9, thereby enforcing stricter controls on hemp products in the state. The prohibition directly impacts producers and retailers of hemp products, potentially limiting their market and requiring them to adjust their formulations to comply with these new limits.

Summary

Senate Bill 180, also known as SB180, seeks to enhance the regulation of cannabis products by establishing clearer labeling and information guide requirements. This bill empowers the therapeutic cannabis oversight board to develop, review, and update product labels and educational materials for cannabis. The intent is to ensure that qualifying patients receive accurate and comprehensive information about the risks associated with cannabis use from alternative treatment centers and certified medical providers. This measure aims to promote better understanding and safe usage among consumers in the state.

Contention

Debates surrounding SB180 may arise around its implications for the hemp industry and therapeutic cannabis access. Proponents emphasize the importance of consumer safety and informed usage, arguing that detailed labeling helps to mitigate risks associated with cannabis consumption. However, opponents may contend that the strict limitations on THC in hemp products could hinder the growth of the hemp market and restrict access to beneficial products that contain higher THC levels. These discussions highlight the balance between regulation for consumer protection and the need for a thriving cannabis industry.